Mechanical circulatory support: Devices, outcomes and complications

Heart Failure Reviews

Volumn 18, Issue 1, 2013, Pages 35-53

  Milano, Carmelo A ^a   Simeone, Alan A ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Circulatory support; Complications; Heart failure; LVAD

Indexed keywords

INOTROPIC AGENT;

ANTICOAGULANT THERAPY; AORTA VALVE REGURGITATION; ARTICLE; ASSISTED CIRCULATION; BRAIN ISCHEMIA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOGENIC SHOCK; CLINICAL DECISION MAKING; CONVALESCENCE; COUNTERPULSATION; DEVICE INFECTION; EQUIPMENT DESIGN; EQUIPMENT FAILURE; HEART AFTERLOAD; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR ASSIST DEVICE; OUTCOME ASSESSMENT; PATIENT SAFETY; PATIENT SELECTION; QUALITY OF LIFE; RIGHT VENTRICULAR ASSIST DEVICE; SURGICAL APPROACH; SURVIVAL TIME; SYSTOLIC HEART FAILURE; TOTAL ARTIFICIAL HEART; TRICUSPID VALVE REGURGITATION;

AGED; AGED, 80 AND OVER; EQUIPMENT DESIGN; EQUIPMENT SAFETY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84871943177     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-012-9303-5     Document Type: Article

References (106)

1. Liotta D, Hall CW, Henly WS, Cooley DA, Crawford ES, DeBakey ME (1963) Prolonged assisted circulation during and after cardiac or aortic surgery: prolonged partial left ventricular bypass by means of intracorporeal circulation. Am J Cardiol 12(3):399-405
2. DeBakey ME (1971) Left ventricular bypass pump for cardiac assistance. Clinical experience. Am J Cardiol 27(1):3-11
3. Cooley DA, Liotta D, Hallman GL, Bloodwell RD, Leachman RD, Milam JD (1969) Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol 24(5):723-730
4. Gaitan BD, Thunberg CA, Stansbury LG, Jaroszewski DE, Arabia FA, Griffith BP, Grigore AM (2011) Development, current status, and anesthetic management of the implanted artificial heart. J Cardiothorac Vasc Anesth 25(6):1179-1192
5. Hill JD (1986) Use of a prosthetic ventricle as a bridge to cardiac transplantation for postinfarction cardiogenic shock. N Engl J Med 314(10):626-628 (Pubitemid 16132728)
6. Pierce WS, Parr GVS, Myers JL, Pae WE, Bull AP, Waldhausen JA (1981) Ventricular-assist pumping in patients with cardiogenic shock after cardiac operations. N Engl J Med 305(27):1606-1610 (Pubitemid 12169188)
7. McBride LR, Naunheim KS, Fiore AC, Moroney DA, Swartz MT (1999) Clinical experience with 111 thoratec ventricular assist devices. Ann Thorac Surg 67(5):1233-1238 (Pubitemid 29320206)
8. Korfer R, El-Banayosy A, Arusoglu L, Minami K, Korner MM, Kizner L, Fey O, Schutt U, Morshuis M, Posival H (2000) Single center experience with the thoratec ventricular assist device. J Thorac Cardiovasc Surg 119(3):596-600 (Pubitemid 30146541)
9. Schoeb R (2000) A bearingless motor for a left ventricular assist device. Paper presented at the International Symposium on Magnetic Bearings, Zurich, Switzerland, August 23-25, 2000
10. McCormick AJ, Reid BB, Budge D, Clayson SE, Revenaugh JR, Stoker S, Raymond AL, Smith HK, Doty JR, Caine WT, Alharethi R, Kfoury AG (2010) 296: versatility and patient outcomes with the levitronix centrimag temporary ventricular assist device. J Heart Lung Transpl 29(2, Supplement 1):S100
11. De Robertis F, Birks EJ, Rogers P, Dreyfus G, Pepper JR, Khaghani A (2006) Clinical performance with the Levitronix Centrimag short-term ventricular assist device. J Heart Lung Transpl 25(2):181-186 (Pubitemid 43156369)
12. John R, Liao K, Lietz K, Kamdar F, Colvin-Adams M, Boyle A, Miller L, Joyce L (2007) Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg 134(2):351-358 (Pubitemid 47088583)
13. Worku B, Takayama H, Van Patten D, Pak P, Naka Y (2010) The Columbia experience with the Levitronix CentriMag as a rescue device in high risk patients. J Heart Lung Transpl 29(2, Supplement 1):S9
14. Bhama JK, Kormos RL, Toyoda Y, Teuteberg JJ, McCurry KR, Siegenthaler MP (2009) Clinical experience using the Levitronix Centrimag system for temporary right ventricular mechanical circulatory support. J Heart Lung Transpl 28(9):971-976
15. Loforte A, Montalto A, Lilla Della Monica P, Musumeci F (2010) Simultaneous temporary CentriMag right ventricular assist device placement in HeartMate II left ventricular assist system recipients at high risk of right ventricular failure. Interact CardioVasc Thorac Surg 10(6):847-850
16. Stepanenko A, Loforte A, Dranishnikov N, Potapov EV, Montalto A, Pasic M, Weng YG, Dandel M, Siniawski H, Kukucka M, Krabatsch T, Musumeci F, Hetzer R (2011) 468 temporary right ventricular support in left ventricular assist device recipients. J Heart Lung Transpl 30(4, Supplement 1):S159-S160
17. Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M (2006) Listing criteria for heart transplantation: International society for heart and lung transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transpl 25(9):1024-1042 (Pubitemid 44311532)
18. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL, Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure Study G (2001) Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345(20):1435-1443
19. Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, Hertz MI, Kfoury AG, Stehlik J (2011) Changing outcomes in patients bridged to heart transplantation with continuous - versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transpl 30(8):854-861
20. Long JW, Healy AH, Rasmusson BY, Cowley CG, Nelson KE, Kfoury AG, Clayson SE, Reid BB, Moore SA, Blank DU, Renlund DG (2008) Improving outcomes with long-term "destination" therapy using left ventricular assist devices. J Thorac Cardiovasc Surg 135(6):1353-1360; discussion 1360-1351
21. Kamdar F, Boyle A, Liao K, Colvin-adams M, Joyce L, John R (2009) Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J Heart Lung Transpl 28(4):352-359
22. Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, Klodell CT Jr, Boyle AJ, John R, Chen L, Massey HT, Farrar DJ, Conte JV (2009) Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 120(23):2352-2357
23. Drews T, Jurmann M, Michael D, Miralem P, Weng Y, Hetzer R (2008) Differences in pulsatile and non-pulsatile mechanical circulatory support in long-term use. J Heart Lung Transpl 27(10):1096-1101
24. Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH (2007) End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. J Heart Lung Transpl 26(8):815-818 (Pubitemid 47199072)
25. Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, Edwards BS, Park S, John R, Conte JV, Farrar DJ, Slaughter MS (2010) Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 55(17):1826-1834
26. Aranda Jr JM, Rogers JG, Aronson KD, Boyle AJ, Russell SD, Edwards B, Zucker MJ, Klodell Jr CT, Sundareswaran KS, Farrar DJ, Slaughter MS, HeartMate IICI (2010) Quality of life improvements are greater in destination therapy than bridge to transplant patients with a continuous flow left ventricular assist device. J Am Coll Cardiol 55(10, Supplement 1):A22.E210-A222.E210
27. Fabienne D, Hilde B, Bart M (2011) To "pump up" quality of life and exercise performance studies in patients with left ventricular assist devices. J Heart Lung Transpl 30(2):141-143
28. Kugler C, Malehsa D, Tegtbur U, Guetzlaff E, Meyer AL, Bara C, Haverich A, Strueber M (2011) Health-related quality of life and exercise tolerance in recipients of heart transplants and left ventricular assist devices: a prospective, comparative study. J Heart Lung Transpl 30(2):204-210
29. Strueber M, O'Driscoll G, Jansz P, Khaghani A, Levy WC, Wieselthaler GM, Heart Ware Investigators (2011) Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol 57(12):1375-1382
30. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW (2007) Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era. Circulation 116(5):497-505 (Pubitemid 47450258)
31. Boyle AJ, Russell SD, Teuteberg JJ, Slaughter MS, Moazami N, Pagani FD, Frazier OH, Heatley G, Farrar DJ, John R (2009) Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transpl 28(9):881-887
32. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, Conte JV, Naka Y, Mancini D, Delgado RM, MacGillivray TE, Farrar DJ, Frazier OH (2007) Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357(9):885-896 (Pubitemid 47347322)
33. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivray TE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH (2009) Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 54(4):312-321
34. Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, Russell SD, Conte JV, Aaronson KD, McGee EC Jr, Cotts WG, DeNofrio D, Pham DT, Farrar DJ, Pagani FD (2011) Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 57(19):1890-1898
35. John R, Naka Y, Smedira N (2011) Outcomes with a continuous flow left ventricular assist device in over 1,000 patients in commercial use compared to clinical trial experience. Paper presented at the Society of Thoracic Surgeons, San Diego, CA
36. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM III, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH (2009) Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361(23):2241-2251
37. Park SJ, Milano CA, Tatooles AJ, Rogers JG, Adamson RM, Steidley DE, Ewald GA, Farrar DJ, Slaughter MS, The HeartMate II Clinical Investigators (2010) Abstract 14430: outcomes in advanced heart failure with left ventricular assist devices for destination therapy. Circulation 122(21 Supplement):A14430
38. Goldstein DJ (2003) Worldwide experience with the MicroMed DeBakey Ventricular Assist Device® as a bridge to transplantation. Circulation 108(10 suppl 1):II-272-II-277
39. Goldstein DJ, Zucker M, Arroyo L, McCarthy P, Noon G (2003) The Micromed-Debakey VAD: initial American experience. J Heart Lung Transpl 22(1, Supplement 1):S218
40. Rothenburger M, Wilhelm MJ, Hammel D, Schmidt C, Tjan TDT, Böcker D, Scheld HH, Schmid C (2002) Treatment of thrombus formation associated with the MicroMed DeBakey VAD using recombinant tissue plasminogen activator. Circulation 106(12 suppl 1):I-189-I-192
41. Loebe M, Noon GP, Benkowski R, Gruber P, Richards T (2007) 103: Improved clinical results with the redesigned MicroMed DeBakey VAD. J Heart Lung Transpl 26(2, Supplement 1):S96-S97
42. Haj-Yahia S, Birks EJ, Rogers P, Bowles C, Hipkins M, George R, Amrani M, Petrou M, Pepper J, Dreyfus G, Khaghani A (2007) Midterm experience with the Jarvik 2000 axial flow left ventricular assist device. J Thorac Cardiovasc Surg 134(1):199-203 (Pubitemid 46962007)
43. Aronson K, Slaughter M, McGee E (2010) Evaluation of the HeartWare HVAD left ventricular assist system for the treatment of advanced heart failure: results of the ADVANCE Bridge to transplant trial. Paper presented at the American Heart Association Scientific Sessions 2010, Chicago, Il, November 2010
44. Slaughter M, Aronson K, Boyce S, Miller L (2011) Evaluation of the HeartWare HVAD left ventricular assist system for the treatment of advanced heart failure: results of the ADVANCE bridge to transplant trial with continued access patients. Paper presented at the International Society of Heart and Lung Transplantation, San Diego, CA, April 2011
45. Morshuis M, El-Banayosy A, Arusoglu L, Koerfer R, Hetzer R, Wieselthaler G, Pavie A, Nojiri C (2009) European experience of DuraHeartTM magnetically levitated centrifugal left ventricular assist system. Eur J Cardiothorac Surg 35(6):1020-1028
46. Loree HM, Bourque K, Gernes DB, Richardson JS, Poirier VL, Barletta N, Fleischli A, Foiera G, Gempp TM, Schoeb R, Litwak KN, Akimoto T, Kameneva M, Watach MJ, Litwak P (2001) The HeartMate III: design and in vivo studies of a maglev centrifugal left ventricular assist device. Artif Organs 25(5):386-391 (Pubitemid 32830469)
47. Jaroszewski DE, Anderson EM, Pierce CN, Arabia FA (2011) The SynCardia freedom driver: a portable driver for discharge home with the total artificial heart. J Heart Lung Transplant 30(7):844-845
48. Slepian MJ (2011) The SynCardia temporary total artificial heart - evolving clinical role and future status. US Cardiol 8(1):39-46
49. Copeland JG, Smith RG, Arabia FA, Nolan PE, Sethi GK, Tsau PH, McClellan D, Slepian MJ (2004) Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med 351(9):859-867 (Pubitemid 39099324)
50. Roussel JC, Sénage T, Baron O, Périgaud C, Habash O, Rigal JC, Treilhaud M, Trochu JN, Despins P, Duveau D (2009) CardioWest (Jarvik) total artificial heart: a single-center experience with 42 patients. Ann Thorac Surg 87(1):124-130
51. Dowling RD, Gray LA, Etoch SW, Laks H, Marelli D, Samuels L, Entwistle J, Couper G, Vlahakes GJ, Frazier OH (2004) Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg 127(1):131-141 (Pubitemid 38160476)
52. Topkara VK, Kondareddy S, Malik F, Wang IW, Mann DL, Ewald GA, Moazami N (2010) Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg 90(4):1270-1277
53. Goldstein DJ, Naftel DC, Holman WL, Bellumkonda L, Pamboukian SV, Pagani FD, Kirklin JK (2011) 7 Driveline Infections in LVADs: is it the pump or the patient? J Heart Lung Transpl 30(4, Supplement 1):S10
54. Bomholt T, Moser C, Sander K, Boesgaard S, Kober L, Olsen PS, Hansen PB, Mortensen SA, Gustafsson F (2011) Driveline infections in patients supported with a HeartMate II: incidence, aetiology and outcome. Scand Cardiovasc J 45(5):273-278
55. Baumblatt JA, Pauwaa S, Treitman A, Gallagher C, Blair C, Pappas P, Tatooles AJ, Bhat G (2011) 6 are blood stream infections associated with increased risk of stroke in patients with a continuous flow left ventricular assist device? J Heart Lung Transplant 30(4, Supplement 1):S9-S10
56. Hannan MM, Husain S, Mattner F, Danziger-Isakov L, Drew RJ, Corey GR, Schueler S, Holman WL, Lawler LP, Gordon SM, Mahon NG, Herre JM, Gould K, Montoya JG, Padera RF, Kormos RL, Conte JV, Mooney ML (2011) Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transpl 30(4):375-384
57. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L (2008) Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 86(4):1227-1234; discussion 1234-1225
58. Geisen U, Heilmann C, Beyersdorf F, Benk C, Berchtold-Herz M, Schlensak C, Budde U, Zieger B (2008) Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 33(4):679-684
59. Crow S, Chen D, Milano C, Thomas W, Joyce L, Piacentino V III, Sharma R, Wu J, Arepally G, Bowles D, Rogers J, Villamizar-Ortiz N (2010) Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg 90(4):1263-1269; discussion 1269
60. Stern DR, Kazam J, Edwards P, Maybaum S, Bello RA, D'Alessandro DA, Goldstein DJ (2010) Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. J Card Surg 25(3):352-356
61. Uriel N, Pak S-W, Jorde UP, Jude B, Susen S, Vincentelli A, Ennezat P-V, Cappleman S, Naka Y, Mancini D (2010) Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol 56(15):1207-1213
62. Crow S, John R, Boyle A, Shumway S, Liao K, Colvin-Adams M, Toninato C, Missov E, Pritzker M, Martin C, Garry D, Thomas W, Joyce L (2009) Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg 137(1):208-215
63. Strueber M, Malehsa D, Avsar M, Jahr N, Bara C, Haverich A (2011) 453 gastrointestinal bleeding after implantation of the HeartWare HVAD left ventricular assist device. J Heart Lung Transpl 30(4):S154
64. Meyer AL, Malehsa D, Bara C, Budde U, Slaughter MS, Haverich A, Strueber M (2010) Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device/clinical perspective. Circ Heart Fail 3(6):675-681
65. Azzouz M, Young SD, Meyer MM, Sun B, Firstenberg MS (2011) Gastrointestinal bleeding in patients with ventricular assist devices: a diagnostic and treatment algorithm. J Heart Lung Transpl 30(4):S154
66. Demirozu ZT, Radovancevic R, Hochman LF, Gregoric ID, Letsou GV, Kar B, Bogaev RC, Frazier OH (2011) Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transpl 30(8):849-853
67. Romano MA, Haft JW, Stulak JM, Aaronson KD, Pagani FD, Cowger J (2011) 9 hemolysis predicts poor outcome following LVAD implant. J Heart Lung Transpl 30(4, Supplement):S11
68. Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B, Russell SD, Starling RC, Chen L, Boyle AJ, Chillcott S, Adamson RM, Blood MS, Camacho MT, Idrissi KA, Petty M, Sobieski M, Wright S, Myers TJ, Farrar DJ (2010) Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transpl 29(4 Suppl):S1-S39
69. Kiernan MS, Pham DT, Denofrio D, Kapur NK (2011) Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics. J Thorac Cardiovasc Surg 142(3):712-714
70. Paluszkiewicz L, Gursoy D, Spiliopoulos S, Dogan G, Daliakopoulos S, Tenderich M, Korfer R, Tenderich G (2011) HeartMate II ventricular assist device thrombosis-an echocardiographic approach to diagnosis: can Doppler evaluation of flow be useful? J Am Soc Echocardiogr 24(3):350 e351-e354
71. Thomas MD, Wood C, Lovett M, Dembo L, O'Driscoll G (2008) Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban. J Heart Lung Transpl 27(8):925-927 (Pubitemid 352024419)
72. Delgado Iii R, Frazier OH, Myers TJ, Gregoric ID, Robertson K, Shah NA, Kar B (2005) Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. J Heart Lung Transpl 24(2):231-233 (Pubitemid 40215604)
73. Krabatsch T, Schweiger M, Stepanenko A, Kukucka M, Vierecke J, Lehmkuhl HB, Huebler M, Hennig E, Potapov E, Hetzer R (2011) Mechanical circulatory support-results, developments and trends. J Cardiovasc Transl Res 4(3):332-339
74. Matthews JC, Koelling TM, Pagani FD, Aaronson KD (2008) The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 51(22):2163-2172 (Pubitemid 351713685)
75. Lee S, Kamdar F, Madlon-Kay R, Boyle A, Colvin-Adams M, Pritzker M, John R (2010) Effects of the HeartMate II continuous-flow left ventricular assist device on right ventricular function. J Heart Lung Transpl 29(2):209-215
76. Kukucka M, Stepanenko A, Potapov E, Krabatsch T, Redlin M, Mladenow A, Kuppe H, Hetzer R, Habazettl H (2011) Right-to-left ventricular end-diastolic diameter ratio and prediction of right ventricular failure with continuous-flow left ventricular assist devices. J Heart Lung Transpl 30(1):64-69
77. Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, Massey T, Milano CA, Moazami N, Sundareswaran KS, Farrar DJ (2010) Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 139(5):1316-1324
78. Baumwol J, Macdonald PS, Keogh AM, Kotlyar E, Spratt P, Jansz P, Hayward CS (2011) Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes. J Heart Lung Transpl 30(8):888-895
79. Iribarne A, Pak S-W, Russo MJ, Easterwood R, Yang J, Takayama H, Mancini D, Naka Y (2011) Incremental cost of right ventricular failure after left ventricular assist device placement. J Am Coll Cardiol 57(14, Supplement 1):E313
80. Ochiai Y, McCarthy PM, Smedira NG, Banbury MK, Navia JL, Feng J, Hsu AP, Yeager ML, Buda T, Hoercher KJ, Howard MW, Takagaki M, Doi K, Fukamachi K (2002) Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 106(12 suppl 1):I-198-I-202
81. Puwanant S, Hamilton KK, Klodell CT, Hill JA, Schofield RS, Cleeton TS, Pauly DF, Aranda JM Jr (2008) Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation. J Heart Lung Transpl 27(10):1102-1107
82. Fitzpatrick JR III, Frederick JR, Hiesinger W, Hsu VM, McCormick RC, Kozin ED, Laporte CM, O'Hara ML, Howell E, Dougherty D, Cohen JE, Southerland KW, Howard JL, Paulson EC, Acker MA, Morris RJ, Woo YJ (2009) Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device. J Thorac Cardiovasc Surg 137(4):971-977
83. Frazier OH, Myers TJ, Gregoric I (2004) Biventricular assistance with the Jarvik FlowMaker: a case report. J Thorac Cardiovasc Surg 128(4):625-626 (Pubitemid 39278402)
84. Stulak JM, Griffith KE, Nicklas JM, Pagani FD (2011) The use of the HeartWare HVAD for long-term right ventricular support after implantation of the HeartMate II device. J Thorac Cardiovasc Surg 142(3):e140-e142
85. Strueber M, Meyer AL, Malehsa D, Haverich A (2010) Successful use of the HeartWare HVAD rotary blood pump for biventricular support. J Thorac Cardiovasc Surg 140(4):936-937
86. Saito S, Sakaguchi T, Miyagawa S, Yoshikawa Y, Yamauchi T, Ueno T, Kuratani T, Sawa Y (2011) Biventricular support using implantable continuous-flow ventricular assist devices. J Heart Lung Transpl 30(4):475-478
87. Stulak JM, Cowger J, Haft JW, Romano MA, Aaronson KD, Pagani FD (2011) 469 the natural history of tricuspid valve and right ventricular function following left ventricular assist device implantation. J Heart Lung Transpl 30(4, Supplement):S160
88. Piacentino V III, Williams ML, Depp T, Garcia-Huerta K, Blue L, Lodge AJ, Mackensen GB, Swaminathan M, Rogers JG, Milano CA (2011) Impact of tricuspid valve regurgitation in patients treated with implantable left ventricular assist devices. Ann Thorac Surg 91(5):1342-1346; discussion 1346-1347
89. Saeed D, Kidambi T, Shalli S, Lapin B, Malaisrie SC, Lee R, Cotts WG, McGee EC Jr (2011) Tricuspid valve repair with left ventricular assist device implantation: is it warranted? J Heart Lung Transpl 30(5):530-535
90. Piacentino V, Troupes C, Ganapathi A, Blue L, Mackensen GB, Swaminathan M, Felker GM, Stafford-Smith M, Lodge AJ, Rogers J, Milano C (2011) Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation. Paper presented at the Society of Thoracic Surgeons Annual Meeting, San Diego, CA
91. Park SJ, Liao KK, Segurola R, Madhu KP, Miller LW (2004) Management of aortic insufficiency in patients with left ventricular assist devices: a simple coaptation stitch method (Park's stitch). J Heart Lung Transpl 127(1):264-266 (Pubitemid 38160493)
92. Adamson RM, Dembitsky WP, Baradarian S, Chammas J, May-Newman K, Chillcott S, Stahovich M, McCalmont V, Ortiz K, Hoagland P, Jaski B (2011) Aortic valve closure associated with HeartMate left ventricular device support: technical considerations and long-term results. J Heart Lung Transpl 30(5):576-582
93. Letsou GV, Connelly JH, Delgado RM III, Myers TJ, Gregoric ID, Smart FW, Frazier OH (2006) Is native aortic valve commissural fusion in patients with long-term left ventricular assist devices associated with clinically important aortic insufficiency? J Heart Lung Transpl 25(4):395-399
94. Matthews JC, Aaronson KD, Jain R, Pagani FD, Kolias TJ (2009) 692: aortic insufficiency - trends over time in LVAD supported patients. J Heart Lung Transpl 28(2, Supplement):S306
95. John R, Mantz K, Eckman P, Rose A, May-Newman K (2010) Aortic valve pathophysiology during left ventricular assist device support. J Heart Lung Transpl 29(12):1321-1329
96. Pak S-W, Uriel N, Takayama H, Cappleman S, Song R, Colombo PC, Charles S, Mancini D, Gillam L, Naka Y, Jorde UP (2010) Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transpl 29(10):1172-1176
97. Cowger J, Pagani FD, Haft JW, Romano MA, Aaronson KD, Kolias TJ (2010) The development of aortic insufficiency in left ventricular assist device-supported patients/clinical perspective. Circ Heart Fail 3(6):668-674
98. Mudd JO, Cuda JD, Halushka M, Soderlund KA, Conte JV, Russell SD (2008) Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. J Heart Lung Transpl 27(12):1269-1274
99. Toda K, Fujita T, Domae K, Shimahara Y, Kobayashi J, Nakatani T (2011) Late aortic insufficiency related to poor prognosis during left ventricular assist device support. Ann Thorac Surg 92(3):929-934
100. Bedi M, Kormos R, Winowich S, McNamara DM, Mathier MA, Murali S (2007) Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol 99(8):1151-1153 (Pubitemid 46562514)
101. Andersen M, Videbaek R, Boesgaard S, Sander K, Hartsen PB, Gustafsson F (2009) Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transpl 28(7):733-735
102. Milano CA, Simeone AA, Blue LJ, Rogers JG (2011) Presentation and management of left ventricular assist device inflow cannula malposition. J Heart Lung Transpl 30(7):838-840
103. Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland JC Jr, Brieke A, Sauer WH (2010) Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device. J Heart Lung Transpl 29(7):771-776
104. Miller LW (2011) Left ventricular assist devices are underutilized/ response to miller. Circulation 123(14):1552-1558
105. Russo MJ, Gelijns A, Aaronson K, Miller L, Hong K, Oz M, Ascheim D, Pagani F, Naka Y, Rose E, Moskowitz A (2010) Changing cost-effectiveness of left ventricular assist devices as destination therapy. J Am Coll Cardiol 55(10, Supplement 1):A18.E169-A118.E169
106. Slaughter MS, Russo M, Bostic R, Rogers J (2010) Abstract 12375: cost effectiveness of continuous-flow left ventricular assist device as destination therapy in advanced heart failure. Circulation 122(21 Supplement):A12375